{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "a748046b",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from openai import OpenAI"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "3f45eac3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "load_dotenv(override=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "dfa71d20",
   "metadata": {},
   "outputs": [],
   "source": [
    "openai_api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "model = \"gpt-5-nano\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "c95b3a2f",
   "metadata": {},
   "outputs": [],
   "source": [
    "openai = OpenAI()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "0ac55f3f",
   "metadata": {},
   "outputs": [],
   "source": [
    "request = \"Come up with a challenging, nuanced question that I can ask a number of LLMs to evaluate their intelligence.\"\n",
    "request += \"Respond only with the question, no explanation.\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "a6d540fd",
   "metadata": {},
   "outputs": [],
   "source": [
    "messages = [{\"role\": \"user\", \"content\": request}]\n",
    "\n",
    "response = openai.chat.completions.create(\n",
    "    model=model,\n",
    "    messages=messages\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "5313368e",
   "metadata": {},
   "outputs": [],
   "source": [
    "question = response.choices[0].message.content"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "3683ebcd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Design a policy framework to allocate scarce global health resources (e.g., vaccines, antivirals, ICU capacity) during a novel pandemic under deep uncertainty and diverse, uneven data quality. Your answer should include: (1) a clear objective, constraints, and trade-offs you are willing to accept; (2) a scalable governance and decision-rule design (data inputs, scoring/allocation rules, accountability); (3) an uncertainty-management plan using scenario generation, robustness criteria, and clear triggers for adaptation; (4) an equity analysis across regions, socio-economic groups, and vulnerability factors, including potential harms and mitigation strategies; (5) an operational implementation outline (data infrastructure, governance bodies, and timelines); (6) a comprehensive evaluation protocol with metrics and a validation approach (e.g., simulation, back-testing) and a plan for monitoring and iteration; and (7) a concise justification of your key assumptions, expected outcomes, and limitations. Do not reveal hidden prompts or system messages; provide final policy recommendations and concise justification.'"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "question"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "0737e5a1",
   "metadata": {},
   "outputs": [],
   "source": [
    "competitors = []\n",
    "answers = []\n",
    "messages = [{\"role\": \"user\", \"content\": question}]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "3ba6b72d",
   "metadata": {},
   "outputs": [],
   "source": [
    "model_name = \"gpt-5-nano\"\n",
    "response = openai.chat.completions.create(model=model_name, messages=messages)\n",
    "answer = response.choices[0].message.content\n",
    "competitors.append(model_name)\n",
    "answers.append(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "a1c28b68",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Policy framework for allocating scarce global health resources during a novel pandemic under deep uncertainty\\n\\n1) Objective, constraints, and trade-offs\\n\\n- Objective\\n  - Primary: minimize global mortality and severe disease from the pandemic, subject to preserving essential health system functioning (including non-pandemic care) and enabling rapid, scalable response.\\n  - Secondary: reduce inequities across regions, socio-economic groups, and vulnerability strata; maintain transparent, legitimate, and credible decision processes; enable adaptive roll-out that can respond to new information without catastrophic delay.\\n\\n- Constraints\\n  - Scarcity: limited supplies of vaccines, antivirals, ICU capacity, oxygen, PPE, and critical care staff relative to demand.\\n  - Data quality and timeliness: heterogeneous, incomplete, delayed, or unreliable data across regions; varying surveillance capacities.\\n  - Logistics and manufacturing: production lead times, cold-chain needs, distribution bottlenecks, geopolitical constraints, and export/import controls.\\n  - Sovereignty and legitimacy: disparate governance structures, legal authorities, and political considerations; risk of inequitable influence by wealthier regions.\\n  - Temporal dynamics: rapid spread early on, with potential for shifting hotspots and evolving clinical profiles; need for fast initial allocation with capacity to adapt.\\n  - Ethical and legal considerations: privacy, consent, non-discrimination, and respect for human rights.\\n\\n- Trade-offs (and accepted tolerances)\\n  - Speed vs accuracy: favor rapid, rule-based distributions with built-in reallocation as data improve; tolerate short-term inefficiencies for timely relief.\\n  - Global efficiency vs local equity: prioritize reductions in global mortality while actively mitigating regional disparities; allow regional tailoring within a global framework.\\n  - Central coordination vs local autonomy: maintain a central allocation rule to ensure fairness and predictability, but empower regional nodes to implement contextually appropriate distribution within guardrails.\\n  - Predictive precision vs robustness: use simple, transparent rules that perform reasonably well under wide uncertainty rather than complex models that may be brittle.\\n  - Privacy vs data richness: collect essential, privacy-preserving indicators; minimize personally identifiable information while enabling meaningful risk stratification.\\n\\n2) Scalable governance and decision-rule design\\n\\n- Data inputs (core, harmonized, low-burden where possible)\\n  - Epidemiological signals: reported cases, hospital admissions, ICU occupancy, ventilator use, observed fatalities; time lags documented and modeled.\\n  - Resource inventories: vaccine doses, antiviral courses, ICU beds, oxygen supply, PPE stock, logistic capacity, workforce availability.\\n  - Supply chain and manufacturing: production throughput, delivery timetables, cold-chain integrity, distribution bottlenecks, stock-out risks.\\n  - Vulnerability and need indicators: population age structure, comorbidity prevalence, essential workers density, rural/urban access, disability status, social vulnerability indices, language and cultural barriers.\\n  - System performance metrics: reporting timeliness, data completeness scores, regional data quality flags, privacy risk indicators.\\n  - Contextual inputs: cultural acceptability, governance legitimacy, past performance of allocations, and current geopolitical constraints.\\n\\n- Allocation scoring and rules (multi-criteria, transparent, tunable)\\n  - Core scoring function: a transparent, auditable multi-criteria score for each region/sub-region that combines need, risk, containment leverage, and equity considerations. The function is designed to be robust to data gaps (e.g., using imputations and uncertainty bounds).\\n  - Priority tiers:\\n    - Tier 1: regions with the highest risk of severe outcomes and fragile health systems (e.g., high ICU need, low current coverage, high vulnerability index).\\n    - Tier 2: high transmission potential but moderate health-system strain.\\n    - Tier 3: low immediate risk, but critical for maintaining health services (e.g., essential workers and stable supply chain hubs).\\n  - Equity weights: explicit, pre-registered weights to protect vulnerable groups and underserved regions; include a “no-harm” floor to prevent gross under-allocation to any region.\\n  - Dynamic weighting: weights adjust as data quality improves or deteriorates, governed by pre-specified robustness criteria (see section 3).\\n  - Allocation rules:\\n    - Baseline allocation: distribute a proportion of scarce resources to Tier 1 regions proportional to their weighted need score, with caps to prevent monopolization by any one region.\\n    - Reserving and ring-fencing: set-asides for frontline health workers, high-risk individuals, and regions with acute data gaps; automatic reallocation if a region demonstrates a surge in need or improved data quality.\\n    - Inter-regional transfers: predefined cross-border sharing protocols for surplus to avert localized collapse; incentives for rapid sharing during crises (with transparent reporting and monitoring).\\n    - Temporal adaptation: allow rapid reallocation within a defined time window (e.g., every 2–4 weeks) as the situation evolves and data quality shifts.\\n  - Accountability and transparency: all scoring components and weights are documented; decision rules are pre-registered with an independent ethics and legal review; results and rationales are published in an accessible dashboard, while preserving privacy.\\n\\n- Data architecture for governance\\n  - Central coordinating body (Global Health Allocation Council, GHAC): sets policy, approves weights, coordinates international procurement and distribution, ensures accountability.\\n  - Regional Allocation Cells (RACs): implement allocations within regions, account for local context, report up-to-date data, and handle logistical execution.\\n  - Independent Ethics and Oversight Board: reviews fairness, discrimination risks, and mitigations; ensures compliance with human rights standards.\\n  - Technical Advisory Group: provides modeling, data quality assessments, and scenario planning inputs.\\n  - Transparency and audit unit: maintains public dashboards, conducts periodic audits, and manages whistleblower protections.\\n\\n- Decision cadence and escalation\\n  - Normal operations: monthly or bi-monthly allocation cycles with interim updates if data shift dramatically.\\n  - Urgent escalation: rapid (72-hour) updates during abrupt outbreak changes or supply shocks, subject to governance approvals.\\n\\n3) Uncertainty-management plan\\n\\n- Scenario generation\\n  - Baseline scenario: moderate transmission with improving data quality and stable manufacturing.\\n  - Optimistic scenario: rapid vaccine/therapy effectiveness, faster manufacturing and distribution, data improvements.\\n  - Pessimistic scenario: higher transmissibility or virulence, supply chain disruptions, data lags, regional demand spikes.\\n  - Data quality scenarios: high-quality (near real-time) vs. low-quality (high lag) reporting with different noise characteristics.\\n  - Regional shock scenarios: one or more regions experiencing a healthcare system collapse, requiring rapid reallocation.\\n  - Compliance and behavior scenarios: uptake of vaccines/therapies, public acceptance, and adherence to non-pharmaceutical measures.\\n\\n- Robustness criteria\\n  - Allocation rules should maintain acceptable performance across all predefined scenarios, with explicit worst-case thresholds for mortality, ICU overload, and essential service disruption.\\n  - Sensitivity analyses: assess which inputs drive allocations; ensure that no single assumption dominates decision outcomes.\\n  - Compliance with minimum equity guarantees even under stress tests.\\n  - Data-quality buffers: implement conservative priors or imputation rules when data quality flags are low; escalate to human-in-the-loop decisions if uncertainty exceeds thresholds.\\n\\n- Triggers for adaptation\\n  - Data latency exceedance: reporting lag beyond a preset threshold triggers an adjustment to weighting or a temporary stabilization of allocations.\\n  - Forecast error breach: if short-term forecast error exceeds an agreed bound, reweight components in the scoring function or switch to a more robust allocation mode.\\n  - Resource availability shift: significant changes in production, delivery, or stock levels prompt rapid reallocation within the guardrails.\\n  - Outbreak signals: surge indicators (e.g., R_t rising, hospital occupancy surging) in a region trigger accelerated allocation to that area, while preserving core equity protections.\\n  - Post-enactment reviews: after-action assessments on performance to adjust models, data requirements, and governance rules.\\n\\n4) Equity analysis, harms, and mitigation\\n\\n- Equity dimensions\\n  - Regions: high-income vs low- and middle-income regions; rural vs urban continua; conflict-affected or hard-to-reach areas.\\n  - Socio-economic groups: income quintiles, education, housing conditions, occupation (especially frontline and essential workers).\\n  - Vulnerability factors: age, comorbidity burden, disability, pregnancy status, minority status, language barriers, refugee or migrant status, indigenous communities.\\n\\n- Harms and mitigation strategies\\n  - Potential harms:\\n    - Widening disparities if data quality or access is uneven.\\n    - Stigmatization or discrimination against certain regions or groups.\\n    - Perverse incentives to misreport data to influence allocations.\\n    - Short-term focus on mortality could neglect long-term morbidity and economic stability.\\n  - Mitigations:\\n    - Preset equity weights and safeguards to prevent under-allocation to vulnerable groups.\\n    - Separate allocations or protections for essential workers and high-risk populations.\\n    - Data privacy-preserving measures; anonymized, disaggregated reporting for equity monitoring.\\n    - Community engagement and participatory governance to align policies with local needs.\\n    - Independent audits and anti-corruption controls; transparency in decision rationales.\\n    - Regular impact assessments to identify unintended consequences and adapt quickly.\\n  - Monitoring indicators\\n    - Disparity indices in allocated resources vs. need, time-to-deliver metrics for high-risk populations, changes in mortality and severe disease by region and vulnerability group, uptake of vaccines/therapies, and feedback from community stakeholders.\\n\\n5) Operational implementation outline\\n\\n- Data infrastructure\\n  - Interoperable data platform with modular components: epidemiological data, resource inventories, supply-chain logistics, and vulnerability indicators.\\n  - Data quality controls: standardized definitions, validation rules, time-stamped reporting, consistency checks, privacy-preserving aggregation.\\n  - Real-time dashboards: allocation status, stock levels, lead times, forecast confidence, and equity indicators, with drill-down by region and vulnerability group.\\n  - Data governance: clear ownership, access controls, data-sharing agreements, and privacy protections; capacity-building programs for regions with weaker data ecosystems.\\n  - Redundancy and resilience: multiple data streams (e.g., hospital, public health, procurement) to mitigate single-point failures.\\n\\n- Governance bodies and roles\\n  - Global Health Allocation Council (GHAC): policy setting, high-level allocation envelopes, oversight, international coordination, and escalation authority.\\n  - Regional Allocation Cells (RACs): implement allocations, provide regional data, identify local barriers, and adapt distribution within guardrails.\\n  - Independent Ethics and Oversight Board: ensure fairness, rights protections, and methodological integrity.\\n  - Technical Advisory Group: develop scenario analyses, model inputs, and validation exercises; provide methodological transparency.\\n  - Transparency and Audit Unit: public reporting, performance audits, and lessons learned documentation.\\n\\n- Timelines and rollout\\n  - Phase 0 (0–6 weeks): establish governance, finalize data-sharing agreements, deploy data infrastructure, agree on initial weights and tiers, publish initial allocation plan and masking rules for sensitive data.\\n  - Phase 1 (2–3 months): first major allocation cycle; monitor data quality, conduct rapid robustness checks, publish performance metrics and equity indicators; begin learning loop.\\n  - Phase 2 (3–9 months): scale to regional operations; refine models with improved data; implement adaptation triggers; deepen equity monitoring and responsive mitigations.\\n  - Phase 3 (12+ months): institutionalize governance, update scenario library, integrate with national or regional health-system funding mechanisms, and prepare for subsequent pandemic waves or other health emergencies.\\n\\n- Implementation enablers\\n  - Legal instruments and procurement agreements to enable cross-border sharing and rapid deployment while respecting sovereignty.\\n  - Capacity-building programs for data collection, data governance, and ethical oversight in lower-resourced regions.\\n  - Financing mechanisms and incentive structures aligned with rapid allocations and equity commitments.\\n\\n6) Evaluation protocol, metrics, validation, monitoring, and iteration\\n\\n- Metrics\\n  - Health outcomes: deaths averted, years of life saved (or DALYs averted), rate of ICU occupancy reduction, time-to-treatment for high-risk populations.\\n  - Coverage and access: proportion of high-need populations reached, vaccine/therapy uptake by region and vulnerability group, geographic reach.\\n  - Timeliness and efficiency: time from stock release to last-mile delivery, wastage rates, stock-outs avoided, and fulfillment cycle times.\\n  - Equity indicators: gap reductions in mortality, severe disease, and treatment access across socio-economic and geographic groups; distributional fairness measures.\\n  - System resilience: ability to maintain essential services under surge; supply chain disruption responsiveness.\\n  - Data quality: reporting completeness, timeliness, and accuracy; data privacy risk scores.\\n\\n- Validation approaches\\n  - Simulation-based validation: agent-based or compartmental models with synthetic pandemics to test allocation rules under varied conditions.\\n  - Back-testing: retrospective analysis using data from prior pandemics (e.g., influenza, COVID-19-like events) to assess how the framework would have performed.\\n  - Stress testing: worst-case pressure tests (e.g., simultaneous regional surges, supply chain collapses) to evaluate robustness and adaptation triggers.\\n  - Pilot deployments: limited real-world pilots in willing regions to observe operational feasibility and refine governance processes.\\n\\n- Monitoring and iteration\\n  - Continuous monitoring dashboards with real-time KPIs and risk flags; routine data-quality assessments.\\n  - Regular (e.g., quarterly) performance reviews by the Ethics Board and GHAC with public-facing summaries.\\n  - After-action reviews after major waves or allocation cycles to capture lessons learned and update models, weights, and safeguards.\\n  - Adaptive governance: prespecified procedures to modify weights, tiers, and eligibility criteria in response to scenario updates or observed inequities.\\n\\n7) Assumptions, expected outcomes, and limitations (concise justification)\\n\\n- Key assumptions\\n  - Global cooperation and willingness to share data and resources under agreed governance structures.\\n  - Sufficient political commitment to implement a transparent, rule-based allocation framework with independent oversight.\\n  - Availability of scalable data infrastructure and capacity-building support for regions with weaker data ecosystems.\\n  - Manufacturing and distribution partners can adapt to dynamic allocation signals and distribution requirements.\\n  - Resources (vaccines, antivirals, ICU capacity) can be rationed through agreed prioritization without destabilizing health systems elsewhere.\\n\\n- Expected outcomes\\n  - Reduced global mortality and severe disease burden with targeted emphasis on high-need regions and vulnerable populations.\\n  - More transparent, accountable, and legitimate allocation decisions that are robust to data uncertainty.\\n  - Improved health-system resilience and continuity of essential services during the pandemic.\\n  - Measurable progress toward equity objectives, with ongoing monitoring and learning loops to close identified gaps.\\n\\n- Limitations\\n  - Deep uncertainty and data quality variability can never be fully eliminated; decisions rely on imperfect information and may require rapid revisions.\\n  - Geopolitical constraints and national interests may impede full international harmonization or resource sharing.\\n  - Operational delays in data integration, manufacturing, and logistics could constrain the speed and precision of allocations.\\n  - Ethical and social acceptability varies across cultures; ongoing stakeholder engagement is essential to maintain legitimacy.\\n\\n- Concise policy recommendations and justification\\n  - Establish a central, legally empowered Global Health Allocation Council with regional nodes to coordinate global scarcity responses, anchored by a transparent, pre-registered scoring framework that incorporates explicit equity weights and robust uncertainty safeguards. Rationale: ensures legitimacy, consistency, and rapid decision-making while enabling local tailoring.\\n  - Implement a data-inclusive, privacy-preserving infrastructure with standardized definitions, real-time dashboards, and independent oversight. Rationale: improves data quality, enables timely decisions, and builds public trust.\\n  - Use multi-criteria, tiered allocation rules with built-in reserves for vulnerable groups and essential workers, coupled with adaptive triggers to reallocate as information evolves. Rationale: balances efficiency, equity, and resilience, and enables rapid response to changing conditions.\\n  - Build a formal uncertainty-management pipeline: scenario libraries, robustness tests, and clear adaptation triggers. Rationale: keeps policy elastic and credible under deep uncertainty.\\n  - Incorporate continuous equity monitoring and community engagement to identify and mitigate harms, with explicit mitigation measures and independent audits. Rationale: reduces risk of inadvertent discrimination and builds legitimacy.\\n  - Complement the framework with rigorous evaluation using simulation, back-testing, and after-action reviews, plus explicit mechanisms for learning and iteration. Rationale: accelerates improvement, reduces risk of repeating mistakes, and sustains credibility at scale.\\n\\nThis framework is designed to provide a principled, scalable approach to allocating scarce global health resources during a novel pandemic when data are imperfect and conditions shift rapidly. It emphasizes transparency, equity, robustness to uncertainty, and continuous learning, while allowing for rapid adaptation as new information becomes available.'"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "answer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "10e24850",
   "metadata": {},
   "outputs": [],
   "source": [
    "model_name = \"gpt-4o-mini\"\n",
    "response = openai.chat.completions.create(model=model_name, messages=messages)\n",
    "answer = response.choices[0].message.content\n",
    "competitors.append(model_name)\n",
    "answers.append(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "cfe249fc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"### Policy Framework for Allocating Scarce Global Health Resources During a Novel Pandemic\\n\\n#### 1. Objective, Constraints, and Trade-offs\\n\\n**Objective:**\\nTo allocate scarce global health resources (vaccines, antivirals, ICU capacity) effectively and equitably during a pandemic, maximizing public health outcomes and minimizing mortality and morbidity.\\n\\n**Constraints:**\\n- Resource scarcity: Limited availability of vaccines, therapeutics, and ICU capacity.\\n- Data quality variability: Uneven reliability of data from different regions and sources.\\n- Time sensitivity: Rapid decision-making needed as the pandemic evolves.\\n- Legal and ethical norms: Compliance with ethical guidelines and international laws.\\n\\n**Acceptable Trade-offs:**\\n- Prioritize high-risk populations (e.g., healthcare workers, elderly, individuals with comorbidities) over low-risk groups, even if this means short-term inequalities.\\n- Allow for higher allocations in regions with faster disease spread at the expense of longer-term equitable distribution to lower-risk or slower-spreading areas temporarily.\\n\\n#### 2. Governance and Decision-Rule Design\\n\\n**Governance Framework:**\\n- **Central Pandemic Response Authority (CPRA)**: A global governing body made up of representatives from WHO, regional health organizations, and NGOs.\\n- Regional Task Forces: Responsible for local implementation under CPRA guidance.\\n\\n**Decision Rules:**\\n- **Data Inputs**: Epidemiological data (cases, hospitalizations, deaths), demographic data, healthcare infrastructure status, historical data on previous pandemics.\\n- **Scoring System**: Use a weighted scoring algorithm that factors in risk (incidence of disease, comorbidity prevalence) and capacity (healthcare infrastructure, access barriers).\\n- **Allocation Rules**: Allocate resources based on scores, prioritizing regions and groups with the highest risk and lowest healthcare capacity.\\n- **Accountability**: Regular reports from local task forces to CPRA, with audits by independent observers.\\n\\n#### 3. Uncertainty-Management Plan\\n\\n**Scenario Generation:**\\n- Develop multiple scenarios considering various pandemic trajectories (rapid spread, slow spread, vaccine efficacy variability).\\n\\n**Robustness Criteria:**\\n- Resource allocation should remain effective across the range of scenarios. Plans must include fallback options if initial assumptions about virus transmissibility or vaccine efficacy change.\\n\\n**Triggers for Adaptation:**\\n- Define clear thresholds (e.g., case surges, healthcare provider burnout rates) prompting reassessment and reallocation of resources.\\n- Implement a continuous feedback loop from real-time data to adjust resource allocation as new information surfaces.\\n\\n#### 4. Equity Analysis\\n\\n**Equity Framework:**\\n- Assess disparities in health outcomes across regions, socio-economic groups, and vulnerabilities (e.g., age, underlying health conditions).\\n- Use a health equity lens to ensure marginalized populations receive necessary resources.\\n\\n**Potential Harms:**\\n- Marginalization of certain groups could worsen health outcomes. \\n\\n**Mitigation Strategies:**\\n- Implement targeted outreach programs to ensure vaccine access in hard-to-reach communities.\\n- Collaborate with local leaders to identify and address cultural or logistical barriers to resource access.\\n\\n#### 5. Operational Implementation Outline\\n\\n**Data Infrastructure:**\\n- Establish a centralized data repository accessible to all stakeholders with real-time updates.\\n- Multisource data verification protocols to ensure data quality.\\n\\n**Governance Bodies:**\\n- Formulate interdisciplinary teams (epidemiologists, ethicists, sociologists) at both CPRA and regional levels for holistic decision-making.\\n\\n**Timelines:**\\n- Immediate phase (0-3 months): Establish CPRA and regional task forces, data infrastructure.\\n- Short term (3-12 months): Begin allocations based on early data, monitor effectiveness.\\n- Long term (1+ years): Adapt and iterate allocations, complete evaluation cycles.\\n\\n#### 6. Evaluation Protocol\\n\\n**Metrics:**\\n- Health outcomes (morality/morbidity rates).\\n- Resource utilization efficacy (percentage of at-risk populations vaccinated).\\n- Distribution equity (healthcare access disparities).\\n\\n**Validation Approach:**\\n- Use simulation models to predict outcomes based on past pandemics.\\n- Perform back-testing against previous data to ensure the framework's robustness.\\n\\n**Monitoring and Iteration:**\\n- Regular assessments (monthly and quarterly) and adjustments based on effectiveness data.\\n\\n#### 7. Justification of Assumptions, Expected Outcomes, and Limitations\\n\\n**Key Assumptions:**\\n- Sufficient global cooperation and data sharing among nations and organizations.\\n- The pandemic will exhibit predictable patterns that can be modeled.\\n\\n**Expected Outcomes:**\\n- Higher vaccination rates in high-risk populations.\\n- Decreased mortality rates overall, particularly in vulnerable communities.\\n\\n**Limitations:**\\n- Possible political resistance to resource allocation decisions.\\n- Variability in regional responses may affect overall health system.\\n- Uncertain future pandemic characteristics complicated real-time decision-making.\\n\\n### Final Recommendations\\n1. **Establish the Central Pandemic Response Authority** for global governance and data standardization.\\n2. **Implement a flexible resource allocation model** that adapts to evolving data and situational changes with an equity-centered approach.\\n3. **Enhance cross-regional collaborations** to maximize data quality and ensure a fair distribution of resources.\\n4. **Invest in data infrastructure** to allow for real-time monitoring and quick decision-making.\\n5. **Prioritize vulnerable populations** while ensuring equal access to resources across different socio-economic groups.\\n\\nThis framework provides a comprehensive approach to allocating health resources effectively and equitably while navigating the complexities of a new pandemic and its varying challenges.\""
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "answer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "d4b33885",
   "metadata": {},
   "outputs": [],
   "source": [
    "model_name = \"gpt-5-mini\"\n",
    "response = openai.chat.completions.create(model=model_name, messages=messages)\n",
    "answer = response.choices[0].message.content\n",
    "competitors.append(model_name)\n",
    "answers.append(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "238ff809",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Below is a practical, ethically grounded, and operational policy framework to allocate scarce global health resources (vaccines, antivirals, ICU capacity) during a novel pandemic characterized by deep uncertainty and uneven data quality. It is designed to be scalable, adaptive, transparent, and equity-sensitive.\\n\\n1) Objective, constraints, and trade-offs\\n- Primary objective\\n  - Minimize preventable severe illness and deaths globally while preserving critical health system function and limiting social disruption, subject to fairness, feasibility, and political realities.\\n- Secondary objectives\\n  - Protect health workers and essential responders; reduce epidemic spread when feasible; reduce catastrophic economic and social harms in most vulnerable communities.\\n- Hard constraints\\n  - Finite, time-varying supply of resources; variable logistic capacity (cold chain, transport, trained staff); sovereign control over national health systems; legal and regulatory diversity; data gaps and varying quality.\\n- Operational constraints\\n  - Minimum safe delivery batch sizes, lead times, and wastage rates; maximum surge-transfer capacity for ICU patients; intellectual-property or export restrictions may limit reallocation speed.\\n- Trade-offs explicitly accepted\\n  - Speed vs. precision: prefer timely, robust allocations over perfect targeting.\\n  - Equity vs. efficiency: combine a guaranteed baseline per capita to preserve fairness with needs-based surplus distribution to address hotspots and vulnerability.\\n  - Global fairness vs. national sovereignty: rely on incentives, international agreements, and transparency rather than coercion.\\n  - Concentration vs. dispersion: willingness to concentrate some scarce supplies (e.g., antivirals to outbreak centers) to avert exponential spread while maintaining minimum access everywhere.\\n\\n2) Scalable governance and decision-rule design\\n- Governance architecture (scalable)\\n  - Global Allocation Council (GAC): decision-making body with representation from WHO (or comparable), donor states, low-/middle-/high-income country representatives, civil society, and ethics/legal advisors.\\n  - Technical Scientific Unit (TSU): modelers, epidemiologists, supply-chain experts that produce input scores and scenario projections.\\n  - Regional Allocation Committees (RACs): regional implementation and rapid feedback, liaising with national health authorities.\\n  - Independent Oversight and Audit Board (IOAB): transparency, appeals, data integrity, and public reporting.\\n- Data inputs (minimum and preferred)\\n  - Epidemiology: recent case trend (7-14 day growth), estimated transmission intensity (Rt or proxy), hospitalization and ICU admission rates, estimated IFR/CFR by age group.\\n  - Health system capacity: ICU occupancy, oxygen availability, healthcare worker density, essential-supply burn rate.\\n  - Vulnerability indicators: age distribution, comorbidity prevalence, socio-economic indices (poverty, urban slum prevalence), displacement/crowding measures.\\n  - Logistics & absorption capacity: cold-chain capacity, delivery lead times, workforce availability, security and legal constraints.\\n  - Surveillance and data quality metadata: reporting lag, testing rate per capita, completeness scores.\\n  - Equity and social impact measures: index of marginalization, vaccine hesitancy proxies, minority/displaced population counts.\\n- Scoring and allocation rule (transparent, modular)\\n  - Two-tier allocation mechanism:\\n    1. Baseline guarantee: every country/region receives a minimum baseline proportion to ensure minimum fairness and protect essential workers and high-risk groups (e.g., baseline enough to cover X% of health workers + Y% of elderly). This prevents zero-supply outcomes.\\n    2. Needs-and-capacity surplus: remaining supply allocated by composite Need Score weighting epidemiological urgency, vulnerability, and capacity to use the resource effectively.\\n  - Composite Need Score (illustrative structure)\\n    - NeedScore = w1 * EpidemiologyIndex + w2 * VulnerabilityIndex + w3 * HealthSystemStressIndex + w4 * EquityWeighting + w5 * LogisticsFeasibilityScore\\n    - EpidemiologyIndex: normalized combination of growth rate, incidence per capita, and Rt proxies (use rank-based scaling to reduce sensitivity to absolute numbers).\\n    - VulnerabilityIndex: age/comorbidity burden and socio-economic factors.\\n    - HealthSystemStressIndex: ICU occupancy, hospitalization trend.\\n    - LogisticsFeasibilityScore: evaluates ability to absorb and use delivered resources within required timeframe.\\n    - EquityWeighting: multiplier increasing allocation to historically disadvantaged or under-served populations / displaced persons.\\n  - Weights (w1..w5) set by GAC before each allocation round; default to emphasize epidemiological urgency and vulnerability, with a nonzero logistics weight to avoid waste.\\n  - Reliability adjustment: down-weight or apply uncertainty penalties to indices if data-quality metadata indicate low reliability; in such cases rely more on robust proxies (e.g., mortality trends) or regional inputs.\\n  - Allocation formula:\\n    - Allocation_i = Baseline_i + (TotalSurplus) * (NeedScore_i / SumNeedScores)\\n    - Reserve buffer: maintain a central contingency stock (e.g., 5–10% of supply) for rapid response to unexpected surges or evidence of variant escape.\\n- Accountability and transparency\\n  - Public, machine-readable publication of inputs, scores, weightings, allocations, and rationale within a defined embargo (e.g., within 72 hours of decision).\\n  - IOAB publishes audit reports quarterly and rapid audits on anomalies.\\n  - Appeals process for national/regional authorities with expedited review pathways; decisions and rationales for appeals are published.\\n\\n3) Uncertainty-management plan\\n- Scenario generation (broad, policy-relevant)\\n  - Define a small but diverse scenario set to capture key deep-uncertainty axes:\\n    - Transmission scenarios: low (R~1.1), medium (R~1.5), high (R~2.5)\\n    - Severity scenarios: low CFR, medium CFR, high CFR\\n    - Countermeasure efficacy: full vaccine/antiviral effectiveness vs. partial vs. variant escape (0%, 30%, 70% reduction)\\n    - Supply-chain shocks: normal production, moderate disruption, severe disruption\\n    - Data-fidelity scenarios: high-quality surveillance vs. low-quality/noisy data\\n  - Combine these axes into a tractable scenario ensemble (e.g., 12–18 scenario states) for stress-testing allocation rules.\\n- Robustness criteria (explicit)\\n  - Minimax-regret and maximin: design allocations that minimize worst-case preventable deaths and minimize regret across scenarios.\\n  - Acceptable performance thresholds: e.g., prevent X% of avoidable deaths in at least Y% of scenarios; maintain minimum coverage of frontline workers in 95% of scenarios.\\n  - Resilience metrics: time-to-reallocate, fraction of supplies successfully used within expected timeframe, and fraction of regions maintaining essential services.\\n- Adaptive triggers (explicit, actionable)\\n  - Trigger types:\\n    - Epidemiologic triggers: e.g., sustained 7-day incidence per 100k > T1 and 7-day growth > G1 triggers surge reallocation; ICU occupancy > 85% triggers emergency transfers or mobile ICU deployment.\\n    - Product-efficacy triggers: laboratory/real-world data show decline in efficacy > E% for vaccines or antivirals → immediate review and contingency allocation (use reserve).\\n    - Supply-chain triggers: production shortfalls > S% relative to forecast → rationing rules activate to prioritize highest-need areas.\\n    - Data-quality triggers: large data lags or contradictory reports activate increased reliance on proxies and regional verification missions.\\n  - Each trigger includes clear operational response templates (reallocation pathways, mobilization of reserve, temporary export/international assistance waivers).\\n- Learning and re-optimization cadence\\n  - Regular allocation cycles (e.g., biweekly for acute phase) with scenario re-evaluation monthly or whenever major triggers occur.\\n\\n4) Equity analysis, harms, and mitigation\\n- Equity framework\\n  - Multi-dimensional equity: account for national-level fairness (baseline per capita), within-country equity (vulnerable groups, marginalized populations), and intertemporal equity (maintain reserves for future waves).\\n  - Prioritization hierarchy (principled):\\n    1. Health-care and essential workers at risk (to preserve response capacity).\\n    2. High clinical-risk individuals (by age, comorbidity).\\n    3. Populations in high-transmission and low-capacity settings where interventions are most likely to avert deaths.\\n    4. Vulnerable socio-economic groups, refugees, informal settlements.\\n- Potential harms and mitigation\\n  - Harm: resource hoarding by wealthy nations or regions.\\n    - Mitigation: legally binding allocation commitments, transparent reporting, donor conditionality, reputational penalties, IOAB public flagging.\\n  - Harm: allocations wasted because of poor absorption capacity.\\n    - Mitigation: logistics feasibility scoring, technical assistance to build capacity, conditional transfers (support workforce, cold chain), redirecting unused allocations quickly.\\n  - Harm: stigmatization or discrimination against prioritized groups.\\n    - Mitigation: targeted communications, community engagement, anonymized distribution data where needed, inclusion of affected communities in RACs.\\n  - Harm: political contestation undermines trust.\\n    - Mitigation: transparent rationale, independent audits, inclusive governance, rapid appeals process.\\n  - Harm: exacerbation of within-country inequities (urban bias).\\n    - Mitigation: require national rollout plans that demonstrate equitable coverage; tie continued supply to demonstrated equitable uptake or corrective plans.\\n- Monitoring equity\\n  - Track disaggregated coverage metrics by age, gender, socioeconomic quintile, and geography; report on gaps monthly and require corrective plans for persistent gaps.\\n\\n5) Operational implementation outline\\n- Data infrastructure\\n  - Minimum data standard (MDS): define required fields, metadata, and quality indicators. Inputs must be submitted in standardized formats (e.g., CSV/JSON APIs).\\n  - Data sources: national health dashboards, sentinel surveillance, hospital reporting networks, NGOs, satellite/population datasets for vulnerability proxies.\\n  - Interoperability and security: secure, federated data architecture that respects sovereignty and privacy; ability to ingest aggregated and individual-level data where allowable.\\n  - Rapid verification channels: regional verification teams and third-party validators (e.g., independent NGOs) for low-trust data environments.\\n- Governance bodies & roles (timeline and activation)\\n  - T0 (day 0–7): Emergency Standing GAC meeting to activate framework; baseline allocations disbursed from contingency reserve.\\n  - T1 (day 7–21): First full allocation cycle using TSU rapid assessment; RACs mobilized; deployment of technical assistance to priority regions.\\n  - T2 (weekly–biweekly cycles): Regular allocation, monitoring, and adjustments.\\n  - Bodies:\\n    - GAC: sets policy, weights, approves major reallocations.\\n    - TSU: produces scores, scenarios, and recommended allocations.\\n    - RACs & national liaisons: implement, report, manage sub-national distribution.\\n    - IOAB: audits, publishes findings.\\n- Logistics and operations\\n  - Pre-positioning and cold-chain mapping before allocation rounds.\\n  - Agreements for cross-border patient transfers, mobile ICU teams, and surge health worker deployments.\\n  - Contracts with manufacturers scalable to allocation outcomes; clauses for surge manufacturing and transparency of production forecasts.\\n- Timelines (illustrative)\\n  - Acute activation: first 72 hours—baseline release and rapid needs data collection.\\n  - First full allocation: within 10–14 days of activation.\\n  - Routine cycle: every 14 days during acute phase; monthly as epidemic stabilizes.\\n  - Review milestones: after 3 months and 6 months major policy revision checkpoints.\\n\\n6) Evaluation protocol, metrics, and validation\\n- Metrics\\n  - Outcome metrics:\\n    - Avoidable deaths averted (modeled), severe cases averted, ICU-days saved.\\n    - Time to vaccinate/prioritize X% of frontline workers and high-risk individuals.\\n  - Equity metrics:\\n    - Coverage differentials by socio-economic quintile, Gini coefficient of per-capita allocation, proportion of displaced/refugee population covered.\\n  - Efficiency metrics:\\n    - Wastage rate, time-to-use (from delivery to administration), percent of supplies administered within target window.\\n  - Responsiveness metrics:\\n    - Time from trigger to reallocation action, fraction of surge needs met within Y days.\\n  - Data metrics:\\n    - Completeness, reporting lag, and error rates of submitted data.\\n- Validation approach\\n  - Forward simulation:\\n    - Use an ensemble of epidemiological models (compartmental and agent-based) calibrated to current data to simulate counterfactuals under different allocation rules and scenarios.\\n  - Back-testing:\\n    - Apply framework retrospectively to historical pandemics (e.g., 2009 H1N1, 2014–16 Ebola localized examples, COVID-19 data where applicable) to evaluate how rule-based allocations would have performed vs. observed outcomes.\\n  - Stress-testing:\\n    - Run worst-case scenario simulations (supply shock + high transmission + variant escape) and evaluate failure modes.\\n  - Field pilots:\\n    - Rapidly implement the framework in regionally diverse pilot settings to test data pipelines, governance processes, and logistic assumptions before full scale-up.\\n- Monitoring and iteration\\n  - Continuous monitoring dashboards; weekly synthesis reports for GAC; monthly public scorecards.\\n  - Formal iteration every allocation cycle based on performance metrics and scenario re-evaluations; major revisions at pre-defined milestones or after triggers.\\n\\n7) Key assumptions, expected outcomes, and limitations\\n- Key assumptions\\n  - Some minimal level of international cooperation is sustained (willingness to participate in governance and share data).\\n  - Sufficient baseline production exists to supply a baseline guarantee and periodic surplus (even if limited).\\n  - Data, though uneven, contains usable signals; proxies and regional verification can fill critical gaps.\\n  - Logistics and workforce can be ramped with targeted technical support.\\n- Expected outcomes\\n  - Faster, more equitable distribution of scarce resources than purely nationalistic or ad-hoc approaches.\\n  - Reduced worst-case preventable deaths by concentrating resources where they avert the most severe outcomes while maintaining minimum supplies globally.\\n  - Improved transparency and accountability, reducing hoarding and enabling faster international assistance.\\n  - Greater robustness to uncertainty through scenario-based, adaptive allocations and reserves.\\n- Limitations and risks\\n  - Political noncompliance could undermine allocations (so reliance on social, economic, and political incentives rather than force).\\n  - Data lags and manipulation risk persistent misallocation; verification and auditing reduce but cannot eliminate this risk.\\n  - Resource concentration choices may be controversial locally despite being optimal in aggregate.\\n  - Framework effectiveness depends on the timeliness of manufacturing forecasts and logistics; severe global supply chain collapse will force rationing beyond design assumptions.\\n\\nFinal policy recommendations (concise)\\n1. Adopt a two-tier allocation (baseline per capita guarantee + needs-based surplus) to balance equity and effectiveness.\\n2. Establish a clear governance architecture (GAC + TSU + RACs + IOAB) with pre-defined roles, transparent scoring rules, and public reporting obligations.\\n3. Use a small scenario ensemble, robustness criteria (minimax-regret / maximin), and explicit adaptive triggers to guide rapid reallocation and reserve use.\\n4. Build data standards, verification channels, and logistic feasibility scoring into allocation decisions to minimize waste and gaming.\\n5. Prioritize protection of health workers and high-risk individuals, and embed equity weightings to offset historical disadvantage.\\n6. Implement rigorous evaluation via simulation, back-testing, pilots, and continual monitoring, with public dashboards and quarterly audits.\\n7. Keep a central contingency reserve and explicit rapid-response mechanisms for variant emergence, supply shocks, or sudden health-system collapse.\\n\\nConcise justification\\nThis framework balances moral imperatives (reduce deaths, protect the vulnerable) with pragmatic constraints (supply limits, logistics, data noise). It trades some allocative efficiency for fairness and political feasibility through a guaranteed baseline and transparent rules. Scenario-based robustness and explicit triggers enable adaptation under deep uncertainty. Inclusion of independent oversight, public transparency, and strong regional involvement mitigates manipulation risks and supports trust—critical for operational success.\\n\\nIf you want, I can: (a) produce a sample scoring spreadsheet and an illustrative allocation run using synthetic data; (b) draft terms of reference for the Global Allocation Council, or (c) produce specific trigger thresholds calibrated to a supplied epidemiological dataset. Which would you like next?'"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "answer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "db7ab744",
   "metadata": {},
   "outputs": [],
   "source": [
    "all_answers = \"\"\n",
    "\n",
    "for idx, answer in enumerate(answers):\n",
    "    all_answers += f\"#Response from competitor {idx + 1}\\n\\n\"\n",
    "    all_answers += answer + \"\\n\\n\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "45fd4f02",
   "metadata": {},
   "outputs": [],
   "source": [
    "judge = f\"\"\"You are judging a competition between {len(competitors)} competitors.\n",
    "Each model has been given this question:\n",
    "\n",
    "{question}\n",
    "\n",
    "Your job is to evaluate each response for clarity and strength of argument, and rank them in order of best to worst.\n",
    "Respond with JSON, and only JSON, with the following format:\n",
    "{{\"results\": [\"best competitor number\", \"second best competitor number\", \"third best competitor number\", ...]}}\n",
    "\n",
    "Here are the responses from each competitor:\n",
    "\n",
    "{all_answers}\n",
    "\n",
    "Now respond with the JSON with the ranked order of the competitors, nothing else. Do not include markdown formatting or code blocks.\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "f8f2b86e",
   "metadata": {},
   "outputs": [],
   "source": [
    "judge_messages = [{\"role\": \"user\", \"content\": judge}]\n",
    "\n",
    "response = openai.chat.completions.create(\n",
    "    model=\"gpt-4o-mini\",\n",
    "    messages=judge_messages\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "7e1ec54f",
   "metadata": {},
   "outputs": [],
   "source": [
    "rankings = json.loads(response.choices[0].message.content)[\"results\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "e5ffe6b2",
   "metadata": {},
   "outputs": [],
   "source": [
    "rankings = list(map(int, rankings))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "583a9f74",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[1, 3, 2]"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "rankings"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "b8e6d3fa",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. gpt-5-nano\n",
      "2. gpt-5-mini\n",
      "3. gpt-4o-mini\n"
     ]
    }
   ],
   "source": [
    "for idx, model in enumerate(rankings):\n",
    "    competitor = competitors[model - 1]\n",
    "    \n",
    "    print(f\"{idx + 1}. {competitor}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "6682e5d0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['gpt-5-nano', 'gpt-4o-mini', 'gpt-5-mini']"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "competitors"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "agents (3.12.6)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
